Review of thiamine deficiency disorders: Wernicke encephalopathy and Korsakoff psychosis.
Chandrakumar A, Bhardwaj A, 't Jong GW.
J Basic Clin Physiol Pharmacol. 2018 Oct 2;30(2):153-162. doi: 10.1515/jbcpp-2018-0075.
Hazardous drinking and alcohol use disorders.
MacKillop J, Agabio R, Feldstein Ewing SW, Heilig M, Kelly JF, Leggio L, Lingford-Hughes A, Palmer AA, Parry CD, Ray L, Rehm J.
Nat Rev Dis Primers. 2022 Dec 22;8(1):80. doi: 10.1038/s41572-022-00406-1.
After NAS.
Oei JL.
Semin Fetal Neonatal Med. 2019 Apr;24(2):161-165. doi: 10.1016/j.siny.2019.01.012. Epub 2019 Feb 15.
Rhabdomyolysis: an evaluation of 475 hospitalized patients.
Melli G, Chaudhry V, Cornblath DR.
Medicine (Baltimore). 2005 Nov;84(6):377-385. doi: 10.1097/01.md.0000188565.48918.41.
What is the optimum thiamine dose to treat or prevent Wernicke's encephalopathy or Wernicke-Korsakoff syndrome? Results of a randomized controlled trial.
Dingwall KM, Delima JF, Binks P, Batey R, Bowden SC.
Alcohol Clin Exp Res. 2022 Jun;46(6):1133-1147. doi: 10.1111/acer.14843. Epub 2022 May 10.
Infectious Complications of Injection Drug Use.
Marks LR, Nolan NS, Liang SY, Durkin MJ, Weimer MB.
Med Clin North Am. 2022 Jan;106(1):187-200. doi: 10.1016/j.mcna.2021.08.006.
Oxytocin for the treatment of drug and alcohol use disorders.
Lee MR, Weerts EM.
Behav Pharmacol. 2016 Dec;27(8):640-648. doi: 10.1097/FBP.0000000000000258.
Drug-induced malabsorption.
Longstreth GF, Newcomer AD.
Mayo Clin Proc. 1975 May;50(5):284-93.
Severe Exacerbation of Multiple Sclerosis Following Withdrawal of Fingolimod.
Fragoso YD, Adoni T, Gomes S, Goncalves MVM, Parolin LF, Rosa G, Ruocco HH.
Clin Drug Investig. 2019 Sep;39(9):909-913. doi: 10.1007/s40261-019-00804-6.
The syndrome of excited delirium.
Gill JR.
Forensic Sci Med Pathol. 2014 Jun;10(2):223-8. doi: 10.1007/s12024-014-9530-2. Epub 2014 Feb 14.
